Dispelling Myths About Prostate Cancer in Black Communities
Mallorie C. Jones, MA, presented a poster at the AACR Annual Meeting 2024 on the use of a video...
Tag: Prostate cancer
Mallorie C. Jones, MA, presented a poster at the AACR Annual Meeting 2024 on the use of a video...
In the United States, the rates of prostate cancer diagnosis and mortality have been steadily declining over the past decades, and...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
Non-Hispanic black men in the United States are much more likely to develop prostate cancer and to die from...
Rates of diabetes in the United States are increasing. According to statistics from the Centers for Disease Control and...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...